Achmea Investment Management B.V. Abbott Laboratories Transaction History

Achmea Investment Management B.V.

$6.06 Billion
Q3 2024

A detailed history of Achmea Investment Management B.V. transactions in Abbott Laboratories stock. As of the latest transaction made, Achmea Investment Management B.V. holds 110,430 shares of ABT stock, worth $12.6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

110,430

Previous 115,277 4.2%

Holding current value

$12.6 Million

Previous $12 Million 5.1%

% of portfolio

0.21%

Previous 0.21%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $485,039 - $572,576	-4,847 Reduced 4.2%	110,430 $12.6 Million
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $129,035 - $144,035	1,281 Added 1.12%	115,277 $12 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $2.73 Million - $3.02 Million	-24,933 Reduced 17.95%	113,996 $13 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $1.26 Million - $1.54 Million	-13,931 Reduced 9.11%	138,929 $15.3 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $242,741 - $291,249	2,541 Added 1.69%	152,860 $14.8 Million
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $3.38 Million - $3.77 Million	33,553 Added 28.74%	150,319 $16.4 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $1.01 Million - $1.19 Million	10,398 Added 9.78%	116,766 $11.8 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $457,713 - $536,968	4,815 Added 4.74%	106,368 $10.9 Million
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $911,963 - $1.06 Million	-9,425 Reduced 8.49%	101,553 $9.83 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $218,531 - $264,135	-2,141 Reduced 1.89%	110,978 $12.1 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $1.09 Million - $1.33 Million	9,574 Added 9.25%	113,119 $13.4 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $12 Million - $14.6 Million	103,545 New	103,545 $14.6 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $7.97 Million - $11.7 Million	-126,829 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $331,390 - $368,915	-4,221 Reduced 3.22%	126,829 $11 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $887,063 - $961,852	-10,839 Reduced 7.64%	131,050 $11 Million
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $29,880 - $34,850	410 Added 0.29%	141,889 $11.9 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $207,533 - $250,908	-3,134 Reduced 2.17%	141,479 $11.3 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $2.32 Million - $2.63 Million	-35,377 Reduced 19.65%	144,613 $10.5 Million
Q2 2018 Jul 27, 2018	BUY	$57.57 - $63.54 $3.77 Million - $4.16 Million	65,502 Added 57.21%	179,990 $11 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $1.31 Million - $1.48 Million	23,282 Added 25.53%	114,488 $6.86 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $1.98 Million - $2.12 Million	36,908 Added 67.97%	91,206 $5.2 Million
Q3 2017 Nov 09, 2017	SELL	$48.06 - $53.64 $145,141 - $161,992	-3,020 Reduced 5.27%	54,298 $2.9 Million
Q2 2017 Aug 29, 2017	BUY	N/A	57,318	57,318 $2.78 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Abbott Laboratories Transaction History